Literature DB >> 6101692

Diabetes and Coxsackie virus B5 infection.

H Champsaur, E Dussaix, D Samolyk, M Fabre, C Bach, R Assan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6101692     DOI： 10.1016/s0140-6736(80)90731-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  19 in total

Review 1.  Prospects for the prevention and reversal of type 1 diabetes mellitus.

Authors:  Nikolai Petrovsky; Diego Silva; Desmond A Schatz
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  No association between islet cell antibodies and Coxsackie B, mumps, rubella and cytomegalovirus antibodies in non-diabetic individuals aged 7-19 years.

Authors:  W A Scherbaum; W Hampl; P Muir; M Glück; J Seissler; H Egle; H Hauner; B O Boehm; E Heinze; J E Banatvala
Journal:  Diabetologia       Date:  1991-11       Impact factor: 10.122

3.  Coxsackie B4 viruses with the potential to damage beta cells of the islets are present in clinical isolates.

Authors:  T M Szopa; T Ward; D M Dronfield; N D Portwood; K W Taylor
Journal:  Diabetologia       Date:  1990-06       Impact factor: 10.122

4.  Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.

Authors:  S Tracy; K M Drescher; N M Chapman; K-S Kim; S D Carson; S Pirruccello; P H Lane; J R Romero; J S Leser
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Detection of enteroviruses in stools precedes islet autoimmunity by several months: possible evidence for slowly operating mechanisms in virus-induced autoimmunity.

Authors:  Hanna Honkanen; Sami Oikarinen; Noora Nurminen; Olli H Laitinen; Heini Huhtala; Jussi Lehtonen; Tanja Ruokoranta; Minna M Hankaniemi; Valérie Lecouturier; Jeffrey W Almond; Sisko Tauriainen; Olli Simell; Jorma Ilonen; Riitta Veijola; Hanna Viskari; Mikael Knip; Heikki Hyöty
Journal:  Diabetologia       Date:  2017-01-09       Impact factor: 10.122

6.  Morphometric evidence for a striking B-cell reduction at the clinical onset of type 1 diabetes.

Authors:  G Klöppel; C R Drenck; M Oberholzer; P U Heitz
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

Review 7.  On the significance of C2, C4, and factor B polymorphisms in disease.

Authors:  C Rittner; J Bertrams
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

8.  Encephalomyocarditis (EMC) virus-induced diabetes mellitus prevented by Corynebacterium parvum in mice.

Authors:  E Kounoue; S Nagafuchi; M Nakamura; S Nakano; T Koga; M Nakayama; M Mituyama; Y Niho; R Takaki
Journal:  Experientia       Date:  1987-04-15

Review 9.  Diabetes mellitus due to viruses--some recent developments.

Authors:  T M Szopa; P A Titchener; N D Portwood; K W Taylor
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

10.  Human leukocyte interferon treatment of two children with insulin dependent diabetes.

Authors:  K H Rand; A L Rosenbloom; N K Maclaren; J H Silverstein; W J Riley; B E Butterworth; J W Yoon; A H Rubenstein; T C Merigan
Journal:  Diabetologia       Date:  1981-08       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.